-
EP0235589
European procedure
Extract from the Register of European Patents
EP About this file: EP0235589
| EP0235589 - Use of quinolone and naphthyridine antibiotics for the manufacture of ophthalmic medicaments [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 28.08.1993 Database last updated on 24.07.2024 | Most recent event Tooltip | 28.08.1993 | No opposition filed within time limit | published on 20.10.1993 [1993/42] | Applicant(s) | For all designated states WARNER-LAMBERT COMPANY 201 Tabor Road Morris Plains New Jersey 07950 / US | [N/P] |
| Former [1987/37] | For all designated states WARNER-LAMBERT COMPANY 201 Tabor Road Morris Plains New Jersey 07950 / US | Inventor(s) | 01 /
Mich, Thomas F. 915 Sunset Road Ann Arbor, MN 48103 / US | 02 /
Heifetz, Carl L. 2640 Traver Blvd. Ann Arbor, MN 48105 / US | [1992/44] |
| Former [1987/37] | 01 /
Mich, Thomas F. 915 Sunset Road Ann Arbor Michigan 48103 / US | ||
| 02 /
Heifetz, Carl L. 2640 Traver Blvd. Ann Arbor Michigan 48105 / US | Representative(s) | Mansmann, Ivo Gödecke AG Patentwesen Mooswaldallee 1-9 79090 Freiburg / DE | [N/P] |
| Former [1987/37] | Mansmann, Ivo Gödecke AG Patentwesen Mooswaldallee 1-9 D-79090 Freiburg / DE | Application number, filing date | 87101354.6 | 02.02.1987 | [1987/37] | Priority number, date | US19860825007 | 03.02.1986 Original published format: US 825007 | [1987/37] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | EP0235589 | Date: | 09.09.1987 | Language: | EN | [1987/37] | Type: | A3 Search report | No.: | EP0235589 | Date: | 13.12.1989 | Language: | EN | [1989/50] | Type: | B1 Patent specification | No.: | EP0235589 | Date: | 28.10.1992 | Language: | EN | [1992/44] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 27.10.1989 | Classification | IPC: | A61K31/47, A61K31/44 | [1987/37] | CPC: |
A61K31/47 (EP,US);
A61K31/44 (EP,US);
A61P27/02 (EP);
A61P31/04 (EP)
| Designated contracting states | AT, BE, CH, DE, ES, FR, GB, GR, IT, LI, LU, NL, SE [1987/37] | Title | German: | Verwendung von Chinolon und Naphthyridin-Antibiotika zur Herstellung von ophthalmischen Arzneimitteln | [1987/37] | English: | Use of quinolone and naphthyridine antibiotics for the manufacture of ophthalmic medicaments | [1987/37] | French: | Utilisation des quinolones et naphthyridines antibiotiques pour la préparation de médicaments ophthalmiques | [1987/37] | Examination procedure | 02.02.1987 | Examination requested [1987/37] | 18.01.1991 | Despatch of a communication from the examining division (Time limit: M04) | 16.05.1991 | Reply to a communication from the examining division | 10.10.1991 | Despatch of communication of intention to grant (Approval: No) | 14.04.1992 | Despatch of communication of intention to grant (Approval: later approval) | 27.04.1992 | Communication of intention to grant the patent | 25.07.1992 | Fee for grant paid | 25.07.1992 | Fee for publishing/printing paid | Opposition(s) | 29.07.1993 | No opposition filed within time limit [1993/42] | Fees paid | Renewal fee | 08.02.1989 | Renewal fee patent year 03 | 09.02.1990 | Renewal fee patent year 04 | 20.12.1990 | Renewal fee patent year 05 | 22.02.1992 | Renewal fee patent year 06 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [YD]EP0106489 (WARNER LAMBERT CO [US]); | [Y]EP0142426 (MERCK & CO INC [US]) | [A] - ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, vol. 28, no. 6, December 1985, pages 766-772, American Society for Microbiology; M.A. COHEN et al.: "In vitro activity of CI-934, a quinolone carboxylic acid active against gram-positive and -negative bacteria" | [A] - CLINICAL THERAPEUTICS, vol. 9, no. 1, 1986, pages 106-118; R.P. SMITH et al.: "In vitro activity of CI-934 and other antimicrobial agents against gram-positve and gram-negative bacteria" |